Judge’s ruling sets a precedent in patent law for cannabis extracts

Written by Daniel Mollenkamp || 24th May 2019 || Regulatory briefing |

Colorado

North America

United States

Regulation and Legislation

Regulatory briefing

Cannabinoid extracts require human intervention to change them from their natural state, a judge has ruled in a dispute that will help develop case law ...

What will European Parliament elections mean for CBD?

Written by CBD-Intel || 23rd May 2019 || Regulatory briefing |

Europe

Policy and Politics

Regulation and Legislation

Regulatory briefing

Many parties taking part in the current European parliamentary elections would like to see more research on the effects of CBD before passing pro-CBD legislation ...

US alcohol bureau won’t approve CBD-infused drinks – at least for now

Written by Daniel Mollenkamp || 20th May 2019 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

The US Alcohol and Tobacco Tax and Trade Bureau (ATTB) has said it will not approve the use of "hemp-CBD" in alcohol products ...

CBD and cannabis news in brief: United States

Written by CBD-Intel || 20th May 2019 || Regulatory briefing |

Colorado

Florida

Indiana

Maine

New Jersey

New York

North America

North Dakota

Tennessee

United States

Regulation and Legislation

Regulatory briefing

The first in a new weekly round-up from around the US brings you news from Colorado, Florida, Indiana, Maine, New Jersey, New York, North Dakota, and Tennessee ...

CBD and cannabis news in brief: International

Written by CBD-Intel || 20th May 2019 || Regulatory briefing |

Asia

Canada

India

North America

World

Companies

Marketing and Retailing

Policy and Politics

Regulation and Legislation

Regulatory briefing

The first in a new weekly round-up from around the world brings you news from India, Canada – and the International Space Station ...

CBD and cannabis news in brief: Europe

Written by CBD-Intel || 20th May 2019 || Regulatory briefing |

Belgium

Czech Republic

EU

Europe

Germany

Lithuania

Netherlands

Switzerland

Policy and Politics

Regulation and Legislation

Regulatory briefing

The first in a new weekly round-up from around Europe brings you news from Belgium, Germany, Switzerland, the Netherlands, the Czech Republic, Lithuania and the EU ...

Tennessee brings ‘smoking hemp’ into its legal lexicon

Written by Daniel Mollenkamp || 17th May 2019 || Regulatory briefing |

North America

Tennessee

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

The Tennessee legislature has enacted a bill which defines "smoking hemp" ...

Salvini’s bid to close down Italy’s CBD trade appears to be an empty threat

Written by CBD-Intel || 16th May 2019 || Regulatory briefing |

Europe

Italy

Marketing and Retailing

Policy and Politics

Regulation and Legislation

Regulatory briefing

The Italian CBD market should not be severely curtailed despite deputy prime minister Matteo Salvini’s threat to destroy the legal cannabis industry ...

Some fear extracts ban as Germany beefs up constraints on CBD sales

Written by CBD-Intel || 14th May 2019 || Regulatory briefing |

EU

Europe

Germany

Companies

Regulation and Legislation

Regulatory briefing

Germany is tightening controls on CBD sales in a move that may lead to a ban on hemp extracts in Europe’s largest market and which has led some chain stores to remove products from shelves ...

Police seize ‘herbal’ stock in raid on ‘UK’s first cannabis restaurant’

Written by Freddie Dawson || 13th May 2019 || Regulatory briefing |

Europe

United Kingdom

Regulation and Legislation

Regulatory briefing

Police have raided what is billed as the UK’s first cannabis restaurant, which features CBD products on its menu, seizing “a significant quantity of herbal cannabis” ...

Belgium makes smokable flower rules clear – but tax plan raises fears

Written by CBD-Intel || 13th May 2019 || Regulatory briefing |

Belgium

EU

Europe

Regulation and Legislation

Regulatory briefing

Regulations on the sale of smokable CBD flower products in Belgium have been clarified. But taxing the products like tobacco could send users to the black market, a campaign group has warned ...

New Zealand’s recreational cannabis referendum won’t affect CBD

Written by Freddie Dawson || 9th May 2019 || Regulatory briefing |

Australasia

New Zealand

Policy and Politics

Regulation and Legislation

Regulatory briefing

A decision on legalising recreational cannabis in New Zealand will go to a referendum to be held next year, but the outcome is not likely to affect the regulatory status of CBD ...

US veterans at odds with federal agency over legalising clinical trials

Written by CBD-Intel || 8th May 2019 || Regulatory briefing |

North America

United States

Policy and Politics

Public Health and Medicine

Regulatory briefing

The US Department of Veterans Affairs has opposed three CBD-related bills in Congress, leading some to wonder if the agency is looking to punish veterans who admit using medical cannabis ...

Will FDA draw a line between other CBD products and pharmaceuticals?

Written by CBD-Intel || 29th April 2019 || Regulatory briefing |

North America

United States

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

The US FDA is to hold a public hearing on 31st May on the safety of products containing cannabis or cannabis-derived compounds ― and stakeholders will be looking for a dividing line ...

When will CBD foods be legal in the US? Don’t hold your breath

Written by CBD-Intel || 25th April 2019 || Regulatory briefing |

North America

United States

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

Could CBD soon be legally sold as a dietary supplement or food in the US? The answer depends on how quickly the federal regulatory framework on cannabis in general and CBD in particular can be eased ...

Hemp growing on the rise, but Ireland still sends abroad for medical supplies

Written by CBD-Intel || 25th April 2019 || Regulatory briefing |

Europe

Ireland

Companies

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

Ireland’s Department of Health still won’t commit to allowing farmers to grow cannabis for medical use, two years after the health minister announced a medical cannabis access programme ...

Child health association ‘an obstacle to cannabis prescriptions,’ claims UK MP

Written by CBD-Intel || 24th April 2019 || Regulatory briefing |

United Kingdom

Policy and Politics

Public Health and Medicine

Regulatory briefing

A UK member of parliament has accused the president of a child healthcare organisation of lying to the parliamentary health and social care committee and dismissing the concerns of families ...

Mexican legalisation may come with added regulation and controls

Written by CBD-Intel || 18th April 2019 || Regulatory briefing |

Mexico

North America

Policy and Politics

Regulation and Legislation

Regulatory briefing

Mexico is well on its way to fully legalising cannabis and its derivative products, but the new government may impose stricter regulation than that left by the previous regime ...

Big Pharma ‘must not be allowed to set EU legal agenda on medical cannabis’

Written by CBD-Intel || 17th April 2019 || Regulatory briefing |

EU

Europe

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

Europe desperately needs harmonised legislation on medical cannabis – but it could take five years, and Big Pharma must not be allowed to set the agenda, delegates at a conference in Brussels heard ...

US attorney general favours bid to let states decide cannabis and CBD policy

Written by Daniel Mollenkamp || 16th April 2019 || Regulatory briefing |

North America

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

US attorney general William Barr has said the current patchwork regulatory situation for CBD in the country is “intolerable” and given qualified support to an act which would allow states to decide their own policies ...

Spain clears up the confusion by clamping down on CBD novel foods

Written by Elba Manzanilla Zapata || 11th April 2019 || Regulatory briefing |

EU

Europe

Spain

Regulation and Legislation

Regulatory briefing

The Spanish Agency for Consumption, Food Safety and Nutrition (AECOSAN) has issued a notice on hemp and cannabinoid use in foods, clarifying its position on European novel food regulations ...

European Commission differentiates CBD as cosmetic ingredient

Written by Pablo Cano Trilla || 10th April 2019 || Regulatory briefing |

EU

Europe

Regulation and Legislation

Regulatory briefing

CBD’s entry in the European Commission’s database of cosmetics ingredients has been expanded to differentiate it from generic cannabis and by-products. The move offers more, but not total, clarity ...

Questions in UK parliament after medical cannabis is seized at airport

Written by CBD-Intel || 9th April 2019 || Regulatory briefing |

Europe

United Kingdom

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

Just two out of around 80 people prescribed medical cannabis in the UK have received products containing THC, with the rest getting CBD, the British parliament has heard ...

Federal assistance proposed for US CBD businesses with banking issues

Written by CBD-Intel || 5th April 2019 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

Proposed new federal legislation in the US could finally help CBD businesses gain easier access to banking, a problem that has bedevilled legal cannabis-related industries since their...

FDA wades in with guidance on CBD – and warnings over ‘deceptive’ claims

Written by Daniel Mollenkamp || 3rd April 2019 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

A high-level working group will explore legal pathways to market for certain CBD products, according to the US FDA – which also revealed it had sent warning letters to three companies it accused of “unfounded claims” ...

Ohio Senate passes bill to establish CBD market, as Texas delists hemp

Written by Freddie Dawson || 3rd April 2019 || Regulatory briefing |

Michigan

North America

Ohio

Texas

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

Ohio is moving a step nearer following its neighbour Michigan in distinguishing hemp-derived CBD products from state cannabis regulations, while Texas is to remove hemp from its list of controlled substances ...

UK government loses a pro-cannabis minister as Brine exits over Brexit

Written by Freddie Dawson || 3rd April 2019 || Regulatory briefing |

United Kingdom

Policy and Politics

Public Health and Medicine

Regulatory briefing

UK member of parliament Steve Brine, a supporter of medical cannabis, has resigned as under-secretary of state for public health over Brexit-related issues ...

EU agriculture committee approves proposal to raise THC limit to 0.3%

Written by CBD-Intel || 3rd April 2019 || Regulatory briefing |

EU

Europe

Regulation and Legislation

Regulatory briefing

The European Parliament’s agriculture committee has approved proposals to put forward an amendment to the Common Agriculture Policy allowing hemp farmers to grow varieties with as much as 0.3% THC ...

Mexican regulatory body repeals guidelines amid confusion

Written by Pablo Cano Trilla || 29th March 2019 || Regulatory briefing |

Mexico

North America

Regulation and Legislation

Regulatory briefing

The Mexican Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) has changed its mind over the regulatory framework established for cannabis products in late 2018 ...

Philippines moves one step closer to legalising medical cannabis

Written by ECigIntelligence || 29th March 2019 || Regulatory briefing |

Asia

Philippines

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

The Philippines moved one step closer to legalising cannabis for medical use when a bill was approved on its final reading, but its progress to law could be scuppered by opposition from president Rodrigo...

Leading UK specialist calls for medical cannabis trials – NICE says yes

Written by Freddie Dawson || 28th March 2019 || Regulatory briefing |

Europe

United Kingdom

Policy and Politics

Regulation and Legislation

Regulatory briefing

The UK’s National Institute for Health and Care Excellence (NICE) promises trials of medical cannabis after a senior consultant told a parliamentary committee of his worries about it being widely prescribed ...

Cannabis troubles – UK committee hears of inconsistency and confusion

Written by CBD-Intel || 26th March 2019 || Regulatory briefing |

United Kingdom

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

Inconsistent quality of products purchased online, and confusion over cannabis itself, could be putting patients at risk, a group of UK MPs were told during presentations on medical cannabis and related issues ...

Cannabis is popular left, right and centre as Israeli election approaches

Written by CBD-Intel || 22nd March 2019 || Regulatory briefing |

Asia

Israel

Policy and Politics

Regulation and Legislation

Regulatory briefing

Politicians in Israel are rarely united on any single issue, but as the much contended Israeli election draws nearer, members from across the political spectrum support the full legalisation of recreational cannabis ...

Contrary to reports, the UK CTA is not suing EU over novel food rules

Written by Freddie Dawson || 20th March 2019 || Regulatory briefing |

EU

United Kingdom

Regulation and Legislation

Regulatory briefing

Lawyers for the UK Cannabis Trades Association (CTA) have confirmed to CBD-Intel that they have not been instructed to sue the EU over novel food guidance for cannabinoids including CBD – contrary to reports ...

Swiss company plans final appeal against 25% tax on cannabis flowers

Written by Freddie Dawson || 19th March 2019 || Regulatory briefing |

Europe

Switzerland

Companies

Regulation and Legislation

Regulatory briefing

An appeal is planned against a Swiss court’s decision that low-THC cannabis flowers should continue to be taxed at the same 25% rate as fine-cut tobacco – a decision that came as no surprise to most Swiss CBD...

There’s room yet for growth and untangling in Canada’s legal reform

Written by CBD-Intel || 18th March 2019 || Regulatory briefing |

Canada

North America

Companies

Policy and Politics

Regulation and Legislation

Regulatory briefing

Nearly five months after Canada legalised cannabis, its fledgling system for delivering cannabis and CBD products to consumers is still experiencing growing pains ...

Will European authorities change their view of cannabinoids?

Written by Freddie Dawson || 15th March 2019 || Regulatory briefing |

EU

Europe

United Kingdom

Policy and Politics

Regulation and Legislation

Regulatory briefing

Lobbyists have highlighted flaws in European authorities’ current classification of cannabinoids as novel foods which could signal change ...

Status and future of CBD oil in Sweden is in the lap of the courts

Written by CBD-Intel || 12th March 2019 || Regulatory briefing |

EU

Europe

Sweden

Regulation and Legislation

Regulatory briefing

The future of CBD oil in Sweden is about to be decided as several cases inch their way through the country’s administrative courts ...

French CBD users warned against buying from illicit online suppliers

Written by CBD-Intel || 7th March 2019 || Regulatory briefing |

EU

Europe

France

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

The French Medicines Agency (Agence Nationale du Médicament, ANSM) has issued a warning to consumers against buying illicit CBD products online ...

More regulatory doubts over CBD in US as FDA commissioner steps down

Written by Freddie Dawson || 7th March 2019 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

The resignation of Food and Drug Administration (FDA) commissioner Scott Gottlieb adds further uncertainty to the future of federal oversight of CBD in the US ...

State by state, US Farm Bill delivers different strokes for different folks

Written by Daniel Mollenkamp || 4th March 2019 || Regulatory briefing |

Colorado

New York

North America

Pennsylvania

Puerto Rico

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

Several US states and territories are reporting changes to hemp policies following the passing of the 2018 US Farm Bill. One surprisingly positive example is Pennsylvania, which is backing growth ...

FDA jurisdiction still unchallenged – but industry presses for clarity

Written by CBD-Intel || 1st March 2019 || Regulatory briefing |

North America

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

The US Food and Drug Administration is moving slowly in drawing regulatory boundaries for CBD businesses. Members of Congress have called for clarity, but the FDA says it has no plans to give cannabis derivatives the green light...

CBD in foods: UK FSA set to issue guidance

Written by Freddie Dawson || 1st March 2019 || Regulatory briefing |

England

Europe

United Kingdom

Wales

Marketing and Retailing

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

The UK Food Standards Agency (FSA) will issue further guidance next week on the use of cannabinoids as novel food ingredients ...

FDA sets the date for hearing on legalising hemp-derived CBD

Written by CBD-Intel || 1st March 2019 || Regulatory briefing |

California

Maine

North America

United States

Wisconsin

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

The US Food and Drug Administration (FDA) has set a tentative date of sometime in April for a long-awaited public meeting to hear from stakeholders and begin a rulemaking process on legalising hemp-derived CBD, according to FDA Commissioner...

Swiss report signals ‘the beginning of the end of cannabis prohibition’

Written by CBD-Intel || 28th February 2019 || Regulatory briefing |

Europe

Switzerland

Policy and Politics

Regulation and Legislation

Regulatory briefing

Growing acceptance and use of CBD in Switzerland, as demonstrated in a recent report, could eventually lead to legalisation of cannabis in the country, according to a range of experts ...

First cases of CBD shops allowed to reopen, but France remains confused

Written by CBD-Intel || 27th February 2019 || Regulatory briefing |

EU

Europe

France

Regulation and Legislation

Regulatory briefing

The French CBD market looks more promising as shops shut down last year through legal action have begun to re-open – though elsewhere in the country others are still being closed and their owners prosecuted ...

Confusion abounds in the tangle of US states’ CBD enforcement

Written by Daniel Mollenkamp || 26th February 2019 || Regulatory briefing |

Alabama

Idaho

Maine

Michigan

Nebraska

New York

North America

Ohio

South Carolina

Tennessee

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

Momentum in the American CBD market continues to build, but a confusing patchwork of differing interpretations by various state authorities has led to local officials starting to clamp down on retailers ...

UN narcotics committee postpones vote on CBD and cannabis rules

Written by Freddie Dawson || 26th February 2019 || Regulatory briefing |

Asia

Europe

Japan

Norway

South America

Uruguay

World

Policy and Politics

Regulation and Legislation

Regulatory briefing

The United Nations Committee on Narcotic Drugs (UNCND) has delayed voting on cannabis and CBD recommendations in a move that has upset a number of delegates ...

How will Spanish elections change the outlook for CBD and cannabis?

Written by Pablo Cano Trilla || 26th February 2019 || Regulatory briefing |

Europe

Spain

Policy and Politics

Regulation and Legislation

Regulatory briefing

Whether the left or the right ends up in power – and that is difficult to predict – some form of debate around cannabis could be on the cards following forthcoming general elections in Spain ...

International packaging and disposal standards give guide to compliance

Written by Freddie Dawson || 25th February 2019 || Regulatory briefing |

North America

United States

World

Regulation and Legislation

Regulatory briefing

Proper disposal of cannabis raw materials forms a major part of new work from ASTM International, US-based developer of international voluntary technical standards ...